6 top webinars coming up this week
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Watch this on-demand webinar to find out how Sony’s ID7000 spectral cell analyzer can work in your lab
Dr. Komal Kumar Javarappa shares insights from the multidisciplinary forefront of immuno-oncology, where translational biologists race against time to optimize new cancer therapies
The acquisition will offer greater flow cytometry and imaging multiplexing capabilities to meet needs in protein and cell analysis research
Flow cytometry innovator’s cFluor Reagents now packaged together as a simplified solution for multicolor panels
Trends in biomarker discovery methods and novel techniques advancing research, clinical diagnostics and therapeutic development
Researchers recommend that targeted nutrition should be urgently explored as a counter-measure to mitochondrial damage
Sangmi Han discusses how cell counters have become an integral part of Macrogen’s single-cell RNA sequencing workflow
Join this webinar to discover more about the software and hardware of the new ID7000 spectral analyzer
The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 dyes aim to offer maximal brightness for improved resolution
Which new products made the most difference to your lab work this year?
The DeNovix CellDrop™ Automated Cell Counter has been awarded the Gold Seal of Quality based on outstanding scientist reviews
Explore exclusive interviews, new methods, and free download to help optimize your 3D cell culture
We reveal the cell counters, LC systems and particle size analyzer that have earned one of these coveted awards based on exceptional reviewer feedback
The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors
New dye offers researchers improved brightness to resolve rare and low antigen density populations more easily